875 Shares in Humana Inc. (NYSE:HUM) Bought by SYM FINANCIAL Corp

SYM FINANCIAL Corp acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 875 shares of the insurance provider’s stock, valued at approximately $222,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sanctuary Advisors LLC purchased a new position in shares of Humana in the 2nd quarter worth approximately $3,341,000. AMF Tjanstepension AB grew its holdings in Humana by 166.8% in the third quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock worth $12,686,000 after purchasing an additional 25,041 shares during the last quarter. Czech National Bank increased its position in shares of Humana by 6.8% during the third quarter. Czech National Bank now owns 24,527 shares of the insurance provider’s stock worth $7,769,000 after purchasing an additional 1,564 shares in the last quarter. Park Avenue Securities LLC increased its position in shares of Humana by 17.3% during the third quarter. Park Avenue Securities LLC now owns 4,857 shares of the insurance provider’s stock worth $1,538,000 after purchasing an additional 718 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of Humana by 78.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,352 shares of the insurance provider’s stock valued at $428,000 after purchasing an additional 593 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on HUM shares. Barclays upped their target price on Humana from $253.00 to $255.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 22nd. Royal Bank of Canada decreased their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Truist Financial lifted their target price on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and upped their price target for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, TD Cowen lifted their price objective on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Nineteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus price target of $297.68.

Humana Trading Down 1.2 %

Shares of Humana stock opened at $293.40 on Monday. The firm has a 50-day simple moving average of $275.36 and a two-hundred day simple moving average of $301.75. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a market cap of $35.33 billion, a P/E ratio of 25.99, a price-to-earnings-growth ratio of 2.22 and a beta of 0.55.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.32% of the stock is owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.